Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses

Virology Journal

Volumn 8, Issue , 2011, Pages

  Cai, Yibin ^a,b   Song, Haichen ^c   Ye, Jianqiang ^a,b   Shao, Hongxia ^a,b   Padmanabhan, Rangarajan ^a,b   Sutton, Troy C ^a,b   Perez, Daniel R ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; INFLUENZA A H7N2 VACCINE; INFLUENZA A H9N2 VACCINE; INFLUENZA VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG; INFLUENZA VIRUS HEMAGGLUTININ;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHICKEN; CONTROLLED STUDY; EMBRYO; HATCHING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLUENZA A; INFLUENZA A (H7N2); INFLUENZA A (H9N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A H7N2; INFLUENZA VIRUS A H9N2; MASS IMMUNIZATION; NONHUMAN; PATHOGENICITY; PROTEIN MODIFICATION; QUAIL; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TITRATION; VIRUS TRANSMISSION; VIRUS VIRULENCE; ANIMAL; AVIAN INFLUENZA; CHICK EMBRYO; GENETICS; IMMUNOLOGY; METHODOLOGY; SURVIVAL; VACCINATION; VIROLOGY;

AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS; SPONDIAS PURPUREA;

ANIMALS; CHICK EMBRYO; CHICKENS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H7N2 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; SURVIVAL ANALYSIS; VACCINATION; VACCINES, ATTENUATED;

EID: 78651563272     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-31     Document Type: Article

References (27)

1. Strategies and challenges for eliciting immunity against avian influenza virus in birds. DE Swayne D Kapczynski, Immunol Rev 2008 225 314 331 10.1111/j.1600-065X.2008.00668.x 18837791
2. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. H Song GR Nieto DR Perez, J Virol 2007 81 9238 9248 10.1128/JVI.00893-07 17596317
3. Live attenuated vaccines against influenza; an historical review. MD Wareing GA Tannock, Vaccine 2001 19 3320 3330 10.1016/S0264-410X(01)00045-7 11348696
4. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. DE Swayne JR Beck N Kinney, Avian Dis 2000 44 132 137 10.2307/1592516 10737653
5. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Steel AC Lowen L Pena M Angel A Solorzano R Albrecht DR Perez A Garcia-Sastre P Palese, J Virol 2009 83 1742 1753 10.1128/JVI.01920-08 19073731
6. Alterations in caspase cleavage motifs of NP and M2 proteins attenuate virulence of a highly pathogenic avian influenza virus. OP Zhirnov HD Klenk, Virology 2009 394 57 63 10.1016/j.virol.2009.08.013 19747708
7. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. MS Park J Steel A Garcia-Sastre D Swayne P Palese, Proc Natl Acad Sci USA 2006 103 8203 8208 10.1073/pnas.0602566103 16717196
8. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. J Talon M Salvatore RE O'Neill Y Nakaya H Zheng T Muster A Garcia-Sastre P Palese, Proc Natl Acad Sci USA 2000 97 4309 4314 10.1073/pnas.070525997 10725408
9. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. H Jin B Lu H Zhou C Ma J Zhao CF Yang G Kemble H Greenberg, Virology 2003 306 18 24 10.1016/S0042-6822(02)00035-1 12620793
10. A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. J Steel SV Burmakina C Thomas E Spackman A Garcia-Sastre DE Swayne P Palese, Vaccine 2008 26 522 531 10.1016/j.vaccine.2007.11.032 18093698
11. Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. H Toro DC Tang DL Suarez MJ Sylte J Pfeiffer KR Van Kampen, Vaccine 2007 25 2886 2891 10.1016/j.vaccine.2006.09.047 17055126
12. An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines. D Hickman MJ Hossain H Song Y Araya A Solorzano DR Perez, J Gen Virol 2008 89 2682 2690 10.1099/vir.0.2008/004143-0 18931063
13. Molecular evaluation of responses to vaccination and challenge by Marek's disease viruses. J Tan J Cooke N Clarke GA Tannock, Avian Pathol 2007 36 351 359 10.1080/03079450701557149 17899458
14. Delayed replication of Marek's disease virus following in ovo inoculation during late stages of embryonal development. JM Sharma, Avian Dis 1987 31 570 576 10.2307/1590742 2823773
15. In ovo vaccination technology. CA Ricks A Avakian T Bryan R Gildersleeve E Haddad R Ilich S King L Murray P Phelps R Poston,, et al. Adv Vet Med 1999 41 495 515 full-text 9890038
16. Comparative field evaluations of in ovo applied technology. CJ Williams AS Zedek, Poult Sci 89 189 193 10.3382/ps.2009-00093 20008818
17. A simple method for estimating 50 percent endpoints. LJ Reed H Muench, Am J Hyg 1938 37 493
18. WHO Manual on Animal Influenza Diagnosis and Surveillance. http://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf
19. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. RJ Webby DR Perez JS Coleman Y Guan JH Knight EA Govorkova LR McClain-Moss JS Peiris JE Rehg EI Tuomanen RG Webster, Lancet 2004 363 1099 1103 10.1016/S0140-6736(04)15892-3 15064027
20. A review of avian influenza in different bird species. DJ Alexander, Vet Microbiol 2000 74 3 13 10.1016/S0378-1135(00)00160-7 10799774
21. Avian influenza - diagnosis. DJ Alexander, Zoonoses Public Health 2008 55 16 23 10.1111/j.1863-2378.2007.01082.x 18201322
22. Avian influenza: our current understanding. DL Suarez, Anim Health Res Rev 2010 11 19 33 10.1017/S1466252310000095 20591211
23. Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses. H Kido Y Okumura E Takahashi HY Pan S Wang J Chida TQ Le M Yano, J Mol Genet Med 2008 3 167 175 19565019
24. Pathogenic potential of North American H7N2 avian influenza virus: a mutagenesis study using reverse genetics. CW Lee YJ Lee DA Senne DL Suarez, Virology 2006 353 388 395 10.1016/j.virol.2006.06.003 16828833
25. Avian influenza virus. CW Lee YM Saif, Comp Immunol Microbiol Infect Dis 2009 32 301 310 10.1016/j.cimid.2008.01.007 18457876
26. Comparative field evaluations of in ovo applied technology. CJ Williams AS Zedek, Poult Sci 2010 89 189 93 10.3382/ps.2009-00093 20008818
27. Comparison of in ovo and post-hatch vaccination with particular reference to infectious bursal disease. A review. T Negash SO al-Garib E Gruys, Vet Q 2004 26 76 87 15230052